Limited coverage criteria – terbinafine

Last updated on March 24, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	terbinafine
Strength & form	250 mg tablet

Special Authority criteria	Approval period
For the treatment of severe onychomycosis PLUS Functional disability PLUS Positive KOH or dermatophyte culture of nail from a licensed lab	Initial: three months Renewals: If required, up to three months

Practitioner exemptions

None

Special notes

Terbinafine cream is not eligible for PharmaCare coverage

Special Authority request form(s)

Log in to eForms
HLTH 5328 – General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage criteria – terbinafine

Generic name

Strength & form

Special Authority criteria

Approval period

Practitioner exemptions

Special notes

Special Authority request form(s)